CVS sales & earnings
This article was originally published in The Tan Sheet
Executive Summary
Retailer's sales jumped 24% to $7.91 bil. in the fiscal third quarter (ended Oct. 2) due to the acquisition of Eckerd drugstores, pharmacy benefit management, mail order businesses. The Eckerd purchase negatively impacted net earnings, which decreased 1.7% to $184.6 mil. Same-store sales increased 5.2%, with pharmacy same store sales up 6.8% and front-end same-store sales up 1.8%; same store sales figures will include Eckerd stores beginning in August 2005. President & CEO Tom Ryan reports CVS' "core business is thriving, and the integration of Eckerd's store and PBM businesses is ahead of schedule." The Eckerd deal closed in July (1"The Tan Sheet" Aug. 9, 2004, In Brief)...
You may also be interested in...
Eckerd deal closes
J.C. Penney closes the $4.5 bil. sale of Eckerd drugstore chain July 31, completing deal announced in April (1"The Tan Sheet" April 12, 2004, p. 7). Jean Coutu Group picks up stores and facilities in 13 states in the Northeast. CVS acquires Florida and Texas stores, as well as Eckerd's pharmacy benefits management and mail order businesses...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.